Stockreport

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful pat [Read more]